Filing Details

Accession Number:
0001628280-22-029932
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-14 19:45:02
Reporting Period:
2022-11-10
Accepted Time:
2022-11-14 19:45:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1671284 Bright Health Group Inc. BHG () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1396538 Manuel Kadre C/O Bright Health Group, Inc.
8000 Norman Center Drive, Suite 9000
Minneapolis MN 55437
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-10 64,487 $1.03 414,487 No 4 P Direct
Common Stock Acquisiton 2022-11-11 167,318 $0.95 581,805 No 4 P Direct
Common Stock Acquisiton 2022-11-11 64,888 $1.05 294,888 No 4 P Indirect Kadre Family Partnership, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Indirect Kadre Family Partnership, L.P.
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.99 to $1.05 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.92 to $0.98 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.95 to $1.09 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Reflects securities held by Kadre Family Partnership, L.P., a family limited partnership, of which the Reporting Person is the general partner.